Published in Onkologie on December 01, 1984
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment. J Clin Oncol (2002) 2.86
[Adult-onset Still's disease]. Med Klin (Munich) (1995) 1.39
[Boundaries between ambulatory and inpatient medicine from the viewpoint of an established oncologist in internal medicine]. Med Klin (Munich) (1994) 1.38
Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood (1998) 1.32
Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin? Onkologie (2003) 1.17
Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient? Urology (2000) 1.03
Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study. Eur J Cancer (2003) 0.97
Histological and ultrastructural findings in chloroquine-induced cardiomyopathy. J Mol Med (Berl) (1995) 0.96
Neutrophilic leukemia accompanied by hemorrhagic diathesis: report of two cases. Blut (1987) 0.93
Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer. Melanoma Res (1999) 0.93
Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. Eur J Cancer (2005) 0.91
ADP-ribosylation of nuclear proteins in normal lymphocytes and in low-grade malignant non-Hodgkin lymphoma cells. Eur J Biochem (1980) 0.90
Common variable immunodeficiency syndrome and nodular lymphoid hyperplasia in the small intestine. Endoscopy (1988) 0.88
Images in cardiovascular medicine. Metabolic imaging identifies non-Hodgkin's lymphoma infiltrating heart. Circulation (1998) 0.87
[Relative deficiency of glutathione reductase and or pyruvate kinase in erythrocytes in aplastic anemia and acute leukemia]. Klin Wochenschr (1971) 0.86
[Serum-dependent defects of function of granulocytes (author's transl)]. Dtsch Med Wochenschr (1974) 0.83
[Treatment of metastasising melanoma with a combination of cytostatic agents (author's transl)]. Dtsch Med Wochenschr (1976) 0.81
Characterization and specificity of proscillaridin antibodies. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.81
PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study. Cancer (1984) 0.81
Melanoma risk and residence in sunny areas. EORTC Melanoma Co-operative Group. European Organization for Research and Treatment of Cancer. Br J Cancer (1997) 0.80
Counseling cancer patients on complementary and alternative medicine. Background, theory, and implementation of nationwide counseling facilities. Strahlenther Onkol (2013) 0.80
[Melanoma therapy]. Dtsch Med Wochenschr (1976) 0.80
Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative Group. Melanoma Res (1992) 0.79
Treatment of metastatic colorectal carcinoma with a combination of fluorouracil and recombinant interferon alfa-2b: preliminary data of a phase II study. Semin Oncol (1992) 0.78
[Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)]. Dtsch Med Wochenschr (1978) 0.77
The EORTC Melanoma Group exchange program: evaluation of a multicenter monoclonal antibody study. Int J Cancer (1991) 0.77
Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinoma. Eur J Cancer (1992) 0.77
[Sentinel node biopsy in breast carcinoma. Interdisciplinary agreement consensus of the German Society for Serology for quality controlled application in routine clinical testing]. Pathologe (2004) 0.77
[Abnormal left-ventricular contraction and filling in patients receiving adriamycin for solid tumours (author's transl)]. Dtsch Med Wochenschr (1978) 0.77
N-(phosphonacetyl)-L-aspartate (PALA) in advanced malignant melanoma: a phase II trial of the EORTC Malignant Melanoma Cooperative Group. Eur J Cancer Clin Oncol (1982) 0.77
High tPA-expression in primary melanoma of the limb correlates with good prognosis. Br J Cancer (2000) 0.76
Verapamil in the prevention of adriamycin-induced cardiomyopathy. Klin Wochenschr (1986) 0.76
[Malignant lymphoma and tuberculosis]. Laryngol Rhinol Otol (Stuttg) (1985) 0.76
Presence of immunoglobulin G in human sera binding to carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA). Eur J Cancer (1980) 0.76
[Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study]. Onkologie (1987) 0.76
A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex) with intramuscular formestane in postmenopausal women with advanced breast cancer. Ann Oncol (1999) 0.76
[Maintaining hope by terminal cancer patients. An empirical introspection for general practice from the retrospective viewpoint of an internal medicine oncologist]. Med Klin (Munich) (1998) 0.75
[Individualization of chemotherapy through in vitro predictive determination of the cytostatic sensitivity of malignant tumors]. Dtsch Med Wochenschr (1989) 0.75
Metolazone for severe dilated cardiomyopathy refractory to conventional therapy. Lancet (1990) 0.75
[CA 125 and CA 19-9 in non-Hodgkin's lymphomas]. Dtsch Med Wochenschr (1986) 0.75
Intermittent combination chemotherapy with chlorambucil and prednisone of low-grade malignant non-Hodgkin's lymphomas according to the Kiel classification. J Cancer Res Clin Oncol (1979) 0.75
Human serum deoxythymidine-5'-triphosphatase activity as a parameter in the diagnosis and follow-up of large bowel carcinoma. Cancer Res (1984) 0.75
Demonstration of elevated anti-Lewis antibodies in sera of cancer patients using a carcinoembryonic antigen-polyethylene glycol immunoassay. Cancer Res (1981) 0.75
[Determination of the DNA-dependent RNA polymerase from human leukocytes in a simple cell-free system (author's transl)]. Klin Wochenschr (1973) 0.75
[Persistent monoclonality despite complete remission of MALT lymphomas of the stomach]. Strahlenther Onkol (2001) 0.75
Occurrence of the common acute lymphoblastic leukemia antigen on blast cells of a patient with chronic myelomonocytic leukemia in non-lymphoid blastic phase. Blood (1985) 0.75
[Prognostic factors in lymph node negative breast cancer]. Strahlenther Onkol (2002) 0.75
[Carcinoembryonal antigen (CEA) in the plasma as a tumor associated parameter of the course of metastasizing breast neoplasms]. Verh Dtsch Ges Inn Med (1978) 0.75
[Porgnostic impact of tumor localization in breast cancer]. Strahlenther Onkol (2001) 0.75
Human leukemic lymphocytes--biochemical parameters of the altered differentiation status. Haematol Blood Transfus (1981) 0.75
[High malignant B-cell non-Hodgkin lymphoma of the heart: intravital diagnosis by transesophageal echocardiography controlled biopsy]. Z Kardiol (1997) 0.75
[Endocrine therapy versus observation after R0 resection in node positive prostate cancer]. Strahlenther Onkol (2000) 0.75
[Controversial reform plan. Should early cancer diagnosis be required? (interview by Dr. Beate Schumacher)]. MMW Fortschr Med (2006) 0.75
[Fasciitis with eosinophilia and hypergammaglobulinaemia (author's transl)]. Dtsch Med Wochenschr (1982) 0.75
[High-dose chemotherapy for metastatic breast cancer without certain advantages so far]. Strahlenther Onkol (2000) 0.75
[Free and template-bound RNA polymerase in normal and leukaemic human lymphocytes (author's transl)]. Klin Wochenschr (1976) 0.75
[The results of a modified FAMeth chemotherapy protocol in metastatic stomach carcinoma]. Dtsch Med Wochenschr (1989) 0.75
Terminal Ph1-positive monocytic crisis in chronic myeloid leukemia providing evidence for the promyelocytic origin of monocytes. Klin Wochenschr (1979) 0.75
[Transfer RNA methyltransferases in different hemoblastoses]. Verh Dtsch Ges Inn Med (1973) 0.75
Sensitive detection of carbohydrate determinants on carcinoembryonic antigen preparations by lectin and antibody binding using polyethylene glycol. Cancer Res (1981) 0.75
Phase I-II study of interferon-gamma and eflornithine (DFMO) in patients with advanced renal cell carcinoma, malignant melanoma and colorectal carcinoma. Oncol Rep (1996) 0.75
[Anabolic therapy in metastatic breast cancer]. Med Klin (1981) 0.75
[Adjuvant therapy of melanoma. From non-specific immune stimulants into the future]. Hautarzt (2006) 0.75
[Ophthalmological diagnosis of cytomegalic retinitis (author's transl)]. Klin Monbl Augenheilkd (1974) 0.75
[Possible prevention of adriamycin-induced cardiomyopathy by verapamil. Results of a pilot study]. Klin Wochenschr (1984) 0.75
Advantages of aberration correction for HRTEM investigation of complex layer compounds. J Microsc (2010) 0.75
[Plasma cell colonies from leukaemic bone marrow in vitro. Differentiation by cytological and cytochemical methods (author's transl)]. Klin Wochenschr (1974) 0.75
[Hyperlipoproteinaemia during additional methenolone administration in the treatment of metastasizing carcinoma of the breast]. Dtsch Med Wochenschr (1981) 0.75
[The effect of actinomycin d, acridine dyes and related substances on the biosynthesis of nucleic acids in normal and leukemic white blood cells. Comparative investigation in intact cells and in a cell-free system (author's transl)]. Klin Wochenschr (1975) 0.75
Incidence and treatment of fungal infections in neutropenic patients. Haematol Blood Transfus (1987) 0.75
[DNA directed nucleic acid polymerases in normal and pathologic human leukocytes: increased specific activities and different kinetics of RNA polymerase B in cell nuclei of pathological cells]. Verh Dtsch Ges Inn Med (1973) 0.75
Circadian variation of alpha- amanitine sensitive RNA-synthesis in normal human lymphocytes. Hamatol Bluttransfus (1976) 0.75
[Clinical significance of routine serum CEA determination in postoperative control in colorectal cancer]. Med Welt (1980) 0.75
[Demonstration of circulating CEA or CEA-like antigens and immunoglobulin G containing immune complexes in colorectal carcinoma]. Klin Wochenschr (1984) 0.75
[DNA directed nucleic acid polymerases in normal and pathologic human leukocytes: differentiation, characterization and purification of DNA polymerases I, II and RNA polymerases A, B and their in vitro influence by cytostatics]. Verh Dtsch Ges Inn Med (1973) 0.75
The effect of Fe-coverage on the structure, morphology and magnetic properties of α-FeSi2 nanoislands. Nanotechnology (2012) 0.75
DNA-dependent DNA and RNA polymerases and tRNA-methyl-transferases in human leukemia and differentiating Friend virus leukemia cells. Hamatol Bluttransfus (1974) 0.75
[Angioimmunoblastic lymphadenopathy with dysproteinemia and sclerosing cholangitis]. Dtsch Med Wochenschr (1994) 0.75
[DNA-dependent RNA polymerases in human leukocytes. II different specific activities of the polymerases A and B in acute and chronic leukemia and their prognostic relevance (author's transl)]. Klin Wochenschr (1975) 0.75
[Splenectomy for chronic myeloid leukaemia in the early and late phases (author's transl)]. Dtsch Med Wochenschr (1977) 0.75
[Early judgement on the results in radiation therapy of colorectal cancer: determination of carcinoembryonic antigen (CEA) in blood serum at daily intervals from the beginning of irradiation (author's transl)]. Strahlentherapie (1981) 0.75
[Planning and execution of a clinico-oncologic collective study]. Med Klin (1979) 0.75
Analysis of human sera for carcinoembryonic antigen (CEA) binding proteins by affinity chromatography with CEA-agarose. Eur J Cancer (1979) 0.75
[Normal and modified nucleobases excreted in urine of patients with chronic nyeloproliferative disorders (author's transl)]. Blut (1979) 0.75
[Socio-economic and ethical aspects of ambulatory treatment for neoplasms in Germany]. Folia Med Cracov (2000) 0.75
[Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification]. Verh Dtsch Ges Inn Med (1978) 0.75
[The pharmacokinetics of doxorubicin]. Klin Padiatr (1986) 0.75
Treatment of metastatic gastric carcinoma with a modified FAMTX chemotherapy regimen. Onkologie (1990) 0.75
[Rebound regression after additional hormonal treatment with ethinyl oestradiol of metastasising carcinoma of the breast in females: frequency and clinical significance (author's transl)]. Dtsch Med Wochenschr (1978) 0.75
[Coincidence of Hodgkin's disease and epithelioid-cell granulomatosis in liver and spleen]. Dtsch Med Wochenschr (1976) 0.75
[Cancer during pregnancy]. Strahlenther Onkol (2000) 0.75
[Diagnostic native roentgenology of operated pituitary adenomas (author's transl)]. Rontgenblatter (1976) 0.75
Health economic analysis of fluoropyrimidine-based therapies of colorectal cancer from the perspective of statutory sickness funds. Z Gastroenterol (2005) 0.75